Abstract-Rapid and accurate clot diagnostic systems are needed for the assessment of hemodiluted blood coagulation. We develop a real-time optical coherence elastography (OCE) system, which measures the attenuation coefficient of a compressional wave induced by a piezoelectric transducer (PZT) in a drop of blood, for the determination of viscous properties during the dynamic whole blood coagulation process. The changes in the viscous properties increase the attenuation coefficient of the sample. Consequently, a dynamic blood coagulation status can be monitored by relating changes of the attenuation coefficient to clinically relevant coagulation metrics, including the initial coagulation time and the clot formation rate. This system was used to characterize the influence of activator kaolin and the influence of hemodilution with either NaCl 0.9% or hydroxyethyl starch 6% on blood coagulation. The results show that PZT-OCE is sensitive to coagulation abnormalities and is able to characterize blood coagulation status based on viscosity-related attenuation coefficient measurements. The PZT-OCE can be used as a point-of-care testing tool for diagnosis of coagulation disorders and the monitoring of therapies.
may cause a defect of clot firmness due to fibrinogen deficiency (an early phenomenon) and thrombocytopenia, impair clot stability due to hyperfibrinolysis and factor XIII deficiency (a late phenomenon), and prolong clot generation due to various coagulation factor deficiencies [1] . Infusion therapy is essential in intravascular hypovolemia and extravascular fluid deficits. Severe bleeding requires intensive intravenous fluid infusion, and crystalloids and colloids are commonly used as plasma expanders. Hydroxyethyl starch (HES) is a colloid solution that can be used to replace initial blood loss and to treat hypovolemia during surgeries. The local routine at hospitals is to use HES 130/0.4 (molecular weight 130 kD and substitution degree of 0.4) for hemodynamic stabilization and initial blood loss replacement [1] , [2] . However, crystalloids and colloids have significant anticoagulant side-effects and could cause dilutional coagulopathy. Monitoring early signs of side-effects could avoid the risk [1] . Therefore, prompt monitoring of blood coagulation is essential for the management of hypofibrinogenemia due to hemodilution.
Routine coagulation analysis includes the measurement of activated partial thromboplastin time (aPTT), prothrombin time (PT), platelet count and fibrinogen levels in plasma, which usually take 30 to 60 minutes. Thromboelastography and thromboelastometry (TEG/ROTEM), which are based on viscoelasticity measurements, allow the assessment of clot formation process and fibrin polymerization in whole blood [3] . Point-of-care testing allows individual patient management with specific, targeted, and rapid supplementation of depleted coagulation factors [4] , [5] . However, TEG/ROTEM are not ideal for assessing clot mechanical properties in point-of-care applications due to poor sensitivity and repeatability, difficulties in operation, and lack of standardization [3] , [6] . The poor standardization of TEG/ROTEM may be partly due to the absence of standard clinical protocols and accurate measurements of the stress and strain.
Recently, optical coherence elastography (OCE), employing optical coherence tomography (OCT) to detect sample deformation, sample vibration or shear wave propagation, has been developed to assess tissue biomechanics [7] , [8] . OCT techniques offer distinct features, including spatial resolution of ∼10 μm, acquisition speed above 50 kHz, and three-dimensional, unlabeled and noninvasive imaging [9] [10] [11] . Excitation approaches and elasticity calculation are generally two characteristics of an OCE system. Various excitation approaches have been proposed to induce vibrations in the samples, such as the use of a piezoelectric (PZT) actuator for contact stimulation [12] , the use of an air-puff device for noncontact stimulation [13] , and the application of acoustic radiation force (ARF) for remote excitation [14] [15] [16] . PZT excitation is convenient for applying force onto the surface of a sample and inducing vibrations. For calculation of elasticity, local strain [17] , shear wave velocity [15] , [18] , vibration amplitude [19] [20] [21] and resonance frequency [22] have been developed to assess mechanical properties. OCE based on vibration measurements has the advantage of enabling real-time assessment without complex data capture and analysis. Therefore, the PZT-OCE device can conveniently and sensitively monitor the changes of viscoelastic properties in real-time.
In this study, we report on the development of a PZT-OCE system that enables real-time monitoring of viscosity in a single drop of blood during the dynamic blood coagulation process. Porcine blood was tested as the model because the properties of porcine blood are similar to those of human blood, particularly in the coagulation process. The tests with porcine blood can be regarded as a safe estimation for human blood. First, we validated the feasibility of PZT-OCE for characterization of viscous properties of blood samples. Then we monitored the tracings of viscosity-related attenuation coefficients during blood coagulation and developed coagulation metrics to assess blood coagulation properties. We compared the changes of coagulation metrics between the samples with different concentrations of activator kaolin to validate this method. Finally, we detected the blood coagulation process among the samples with different hemodilution commonly used in infusion therapy.
II. MATERIALS AND METHODS

A. System Setup
The properties of blood coagulation were monitored based on the measurements of viscosity-related attenuation coefficients of blood samples using PZT-OCE. The PZT-OCE system is shown in Fig. 1 . The PZT was driven by one cycle of sine wave with a frequency of 200 Hz and a peak-to-peak voltage of 70.8 v. After a drop of porcine blood with a volume of 200 μL was injected onto the microscope slide, the PZT was moved downwards to touch the top surface of the blood drop, and then the PZT was moved upwards. The distance between the surface of the PZT and the upper surface of the microscope slide was 2 mm. Due to the surface tension of the blood drop, the sample was attached between the PZT and microscope slide, and the thickness of the blood drop was 2 mm throughout the whole measurements. At the beginning of the measurements, the blood drop was attached between the PZT and microscope slide due to the surface tension. During the blood coagulation, the blood drop was attached firmly with the PZT and the slide due to the adhesive force. So the thickness of the blood sample was not changed during the measurements. The contact area between the PZT and the blood drop was ∼ 64 mm 2 (a diameter of ∼9.0 mm) and the contact area between microscope slide and the blood drop was ∼ 141 mm 2 (a diameter of ∼13.4 mm). As the thickness of the blood drop was only 2 mm, the flat structure of the blood drop was relatively stable due to the surface tension and adhesive force during the measurements.
The OCT scan lens was located under the microscope slide, and the OCT beam passed through the slide. The vibrations in the blood drop were detected by the OCT system based on a swept source with a central wavelength of 1310 nm and an A-line speed of 50 kHz. The light from the laser source was split into the sample arm and the reference arm with a power of 90% and 10%, respectively. For vibration detection, 1000 A-lines, corresponding to a total time of 20.0 ms, were recorded in one OCT M-scan during which the PZT amplifier started to drive the PZT at 2.0 ms. The PZT-induced vibration was parallel to the OCT beam and was detected by Doppler phase shift measurements. The Doppler phase shift Δψ measured by the OCT system was used to calculate the vibration velocity V by the following equation:
where λ 0 is the vacuum center wavelength, n is the refractive index, and Δt is the time interval. The parameters of λ 0 and n were 1310 nm and 1.4 [10] , [23] [24] [25] . Due to the limitation of the OCT signal-to-noise ratio, Δψ cannot be accurately measured when V is too low. The increase of Δt will increase the phase change Δψ for the same velocity and, thus, improve the accuracy of the velocity measurement [10] . However, if the time interval Δt is too large, the phase wrap will occur and the unwrapping correction is required. The optimized time interval Δt is 0.10 ms for measurements in the blood samples and is 0.02 ms for measurements on the PZT surface.
B. Sample Preparation for Feasibility Test
The feasibility of PZT-OCE was investigated in the porcine blood. Fresh citrated porcine whole blood (Sierra for Medical Science, CA) of 600 μL was recalcified with buffered CaCl 2 (0.2 mol/L, 40 μL) and gently mixed with the activator kaolin solution (12.8 g/L, 40 μL). The final concentrations of CaCl 2 and kaolin were 0.01 mol/L and 0.75 g/L, respectively. Then, 200 μL of the final reaction mixture was slowly injected onto the microscope slide and immediately measured by the PZT-OCE system.
C. Sample Preparation for Hemodilution Test
In order to quantify the viscosity changes during blood coagulation, the changes in the attenuation coefficient were measured. Then coagulation metrics were calculated, which included the initial coagulation time when the attenuation coefficient started to become larger and the clot formation rate while the attenuation coefficient increased dramatically.
In the first experimental series, different concentrations of activator kaolin solutions (final concentrations of 0.75 g/L and 0.38 g/L) were added to the blood samples. In the feasibility test, three samples for each group were tested for 10 min, and the coagulation metrics were measured. Then, we added kaolin solutions with a final concentration of 0.38 g/L and diluted samples of citrated porcine whole blood with either NaCl 0.9% (Sigma-Aldrich, MO) or VetStarch HES 6% 130/0.4 (Zoetis, NJ). The final concentrations of whole blood were 67% after hemodilution. Following the same procedure, derived coagulation metrics were measured by the PZT-OCE system.
III. RESULTS AND DISCUSSION
A. Feasibility Test
Time-course coagulation of the citrated porcine blood was monitored by measurements of the viscosity-related attenuation coefficient of a compressional wave propagating in the blood drop. After PZT vibration in a cycle of sine wave induced a compressional wave inside the blood drop, the compressional wave propagated from the top surface to the bottom surface of the blood drop. Due to attenuation of a compressional wave during the wave propagation, the displacement amplitude decreased. Based on power-law frequency-dependent attenuation equation in viscoelastic media [26] , [27] :
where A(0) and A(Δx) are the amplitude of a compressional wave at the initial position and the amplitude after the wave travels a distance of Δx, respectively, and α is the frequencydependent attenuation coefficient. The attenuation coefficient α of a compressional wave is associated with the properties of tissue scattering and tissue absorption [28] . In our measurements, the wavelength of the compressional wave was ∼7.5 m (with a wave frequency of 200 Hz and a wave velocity of ∼ 1.5 × 10 3 m/s), which is much larger than the scatters of blood cells (several micrometers). Therefore, the attenuation due to tissue scattering can be ignored. The tissue absorption mechanisms include viscosity and thermal conduction. In comparison to the absorption due to viscosity-related motion, the absorption due to thermal conduction is negligible [28] . Because of the low scattering contributions and the low thermal losses, the attenuation of a compressional wave measured in our study mainly depended on the tissue viscosity with a given wave frequency.
We quantified the attenuation coefficient to assess the tissue viscosity. The ratio of displacement amplitude A(Δx) to A(0) is equal to the ratio of maximum vibration velocity V max (Δx) at the position of Δx to V max (0) at the initial position because the PZT is driven by a sine function in this study and the velocity is the time derivative of the displacement. Equation (2) can be transferred to the following equation:
Thus, the attenuation coefficient α can be calculated by the following equation:
After predetermination of the maximum PZT vibration velocity V max (0), the attenuation coefficient α can be calculated by measurements of the maximum vibration velocity V max (Δx) after the wave travels a distance of Δx. Fig. 2(A) shows the B-mode OCT image at 1 min after kaolin addition. M-scans were captured at the position indicated by the red arrow in Fig. 2(A) and were analyzed by the Doppler phase shift method. The M-scan OCT image captured at 1 min following the recalcification is shown in Fig. 2(B) , and the corresponding Doppler phase image is shown in Fig. 2(C) . From the Doppler phase image, vibration velocities at 1.4 mm away from the PZT surface were analyzed [i.e., the region in the dashed box in Fig. 2(C) ], which is shown in Fig. 2(D) . We also measured the vibration velocities on the PZT surface by Doppler OCT without loading the blood drop, which is shown in Fig. 2(D) . The vibration velocities on the PZT surface and in the blood drop changed over time during one cycle of the PZT excitation and reached a maximum at ∼6.5 ms. The attenuation coefficient α is 1.1 Np/mm when Δx is 1.4 mm, the V max (0) and V max (1.4) are 4.0 mm/s and 0.9 mm/s, respectively. The measurement position in the blood drop is selected in order to get higher OCT signal-to-noise ratios and avoid the distortion due to the reflection of the compressional wave near the surface of the microscope slide. The attenuation coefficient α depends on the viscous property of the blood with a given frequency of sine wave excitation, and is independent on the PZT loading placement.
B. Blood Coagulation With Different Kaolin Concentrations
The tracings of attenuation coefficients during clot formation are shown in Fig. 3(A) , providing information on clot formation kinetics with different kaolin concentrations. The changes of viscosity during blood coagulation were modeled approximately by a logistic function [29] . Fig. 3(B) shows three stages in the sample with a kaolin concentration of 0.38 g/L. In the first stage, the blood is in a liquid state: the initial attenuation coefficient remains almost unchanged. During the second stage, fibrinogen begins to transform into fibrin through coagulation cascade reaction while the blood starts to clot. The attenuation coefficient increases markedly with progressively increasing viscosity. In the final stage, the attenuation coefficient changes to a small extent with an approximate horizontal asymptote corresponding to the stable and maximum viscosity of the clot. The time of the first stage indicates the initial coagulation time and the slope of the second stage characterizes the clot formation rates. In Fig. 3(C) , the coagulation metrics, including the initial coagulation time and the clot formation rate, are compared in the samples with different kaolin concentrations. The initial coagulation time significantly increases in the samples with a lower kaolin concentration (P < 0.01); however, the clot formation rates are similar in two groups of samples (P > 0.05), which correspond with previous studies [16] .
C. Blood Coagulation With Different Diluted Solutions
The tracings of attenuation coefficients in whole blood samples either diluted with NaCl or HES are shown in Fig. 4(A) . Similar to those in whole blood, the tracings in the samples diluted with NaCl can be separated into three distinct stages: a stable liquid state with low viscosity, a rapid transforming state and a stable gel state with high viscosity. The data from whole blood and blood diluted with NaCl were fitted into S-curves. However, in the samples diluted with HES, five distinct stages were observed, including the initial stable liquid state, the first rapid transforming state, the temporary stable state, the second transforming state, and the final stable gel state. The data from blood samples diluted with HES were fitted into double S-curves. The data from the beginning of the first rapid transforming state to the end of the second transforming state were used to calculate the clot formation rates in the samples diluted with HES. In Fig. 4(B) , the initial coagulation time and the clot formation rate are compared among the whole blood samples, the samples diluted by NaCl and the samples diluted by HES. The initial coagulation time is similar in three groups of samples, indicating that the viscosity of these samples starts to change at the similar time. Clot initiation is quite resistant to hemodilution effects. After the blood starts to turn into a gel state, the clot formation rate is not significantly affected by hemodilution with NaCl (P > 0.05) when the whole blood and the samples diluted with NaCl are compared. However, coagulation tracing and clot formation rate are significantly changed when the samples are diluted with HES. Clot formation rate significantly slows down after hemodilution with HES (P < 0.01).
D. Discussion
The approach described here represents a coagulation test by measuring the attenuation coefficient within a very small amount of blood (200 μL). The attenuation coefficient of the compressional wave measured in our study depends on the tissue viscosity with a given wave frequency. Viscosity has been validated to be able to reflect actual coagulation processes [30] . Like most laboratory tests for blood coagulation, our coagulation assessment is made based on in vitro measurements. Coagulation metrics may vary between in vitro and in vivo tests due to the changes in flow conditions and contributions of endothelial cells [6] . However, the quantitative metrics are sensitive to the changes in the coagulation properties from our measurements when the same volume of the blood is tested. More importantly, our measurements conduced on whole blood samples closely resembles the coagulation process in vivo. The foundation of the approach is a PZT-OCE system capable of real-time monitoring of the attenuation coefficient and quantitative measurements of clinically relevant coagulation metrics which, thus, produces assessment of coagulation status.
In order to monitor the blood coagulation, some methods have been proposed based on different physical measurements. Laser speckle rheology was developed to assess blood coagulation status by measurements of Brownian motion related to the viscoelastic properties of the medium [29] . The increase in viscoelasticiy reduces displacements of scatterers and, thus, slows down the rate of speckle fluctuations during the formation of the blood clot. The Brownian motion may be affected significantly by changes in the sizes of scatterers associated with aggregation of red blood cells during blood coagulation [31] . The quartz crystal biosensor, as a mechanical sensor, can detect the viscosity changes based on frequency shift measurements on the surface of a sample during blood coagulation [32] . The coated surface of the quartz sensor is difficult to clean effectively and, thus, the sensor is consumable [33] . The TEG/ROTEM systems generate output by transforming the changes in the viscoelastic strength of clotting blood to the changes in the rotation of a pin in a rotating cuvette for coagulation assessment. The rotation of the pin begins to be triggered after fibrin-platelet bonding has linked the cup and pin together. Thus, the output of TEG/ROTEM is directly related to the strength of the formed clot [6] . However, the large sizes of TEG and ROTEM limit their clinical adoption for point-of-care applications. The complexity of TEG and ROTEM also results in the difficulties in operation [33] . Our PZT-OCE system visualizes the blood clot development in real-time by measurements of attenuation coefficients directly related to the blood viscosity. OCT incorporating Doppler phase shift measurements can sensitively measure the vibration velocity in depth and, thus, accurately quantify the viscosity-related attenuation coefficient. The operation is simple and robust after loading the sample, and the system size can be compact. Recently, the development of low-cost, portable OCT systems further reduces the cost while maintains the desired system performances [34] . Therefore, PZT-OCE has the potential as point-of-care testing for coagulation monitoring.
Acoustic radiation force orthogonal excitation optical coherence elastography (ARFOE-OCE) has also been developed to monitor blood coagulation based on quantitative measurements of shear wave velocities [16] . The application of ultrasonic force with water as a coupling medium may bring inconvenience of the measurements, and shear wave velocity calculation also increased the complexity of data analysis. In order to visualize the shear wave propagation, 1 mL of sample volume was required. Compared with ARFOE-OCE, PZT-OCE measurements simplify the system and data analysis, and only 200 μL of sample volume is used.
We analyzed hemodilution using PZT-OCE in order to mimic blood loss and clinical infusion therapy. The PZT-OCE system successfully identified the difference between NaCl 0.9% and HES 6% in the diluted blood coagulation process. Coagulopathy induced by hemodilution with NaCl 0.9% and HES 6% was characterized, and HES had a more pronounced effect which is in accordance with previous studies [2] . HES 130/0.4, as a pump prime and intraoperative fluid therapy, was reported to significantly slow down clot formation [2] . In our measurements, the clot formation rate significantly slows down when the whole blood samples are diluted with HES.
IV. CONCLUSION
In this study, we developed a PZT-OCE system for monitoring blood coagulation based on the measurements of attenuation coefficients which is related to tissue viscosity with a given PZT driving frequency. The PZT-OCE system could be used to rapidly and conveniently provide information about clot formation process in whole blood. Clinically relevant coagulation metrics, including the initial coagulation time and the clot formation rate, were quantified to characterize the influence of the activator kaolin and the influence of hemodilution with either NaCl or HES on blood coagulation. PZT-OCE has the potential to be developed as point-of-care testing for diagnosis of coagulation disorders and monitoring of therapies, e.g., to characterize the range of acute coagulopathies present in patients with traumatic injury, identify the presence and type of coagulopathy at an early stage and, in turn, reveal the most appropriate treatment options for these patients in emergency settings. ACKNOWLEDGMENT Z. Chen has a financial interest in OCT Medical Imaging Inc., which, however, did not support this work.
